The data-driven approach for regulatory CMC strategy and submissions.

Our one-of-a-kind software combines the power of rules-based programming with industry-specific knowledge. It helps you to meet compliance obligations while significantly improving operational efficiency.

EnkrisiGPT helps you with:
  • Efficient and Accurate Decision-Making: EnkrisiGPT enables sponsors and regulatory scientists to process vast amounts of data efficiently and accurately. By leveraging augmented intelligence, it provides actionable strategies and insights, empowering users to make informed decisions quickly and effectively.
  • Enhanced Regulatory Compliance: EnkrisiGPT serves as an AI-driven tool specifically designed for regulatory compliance. It automates rules-based checks using data, analytics, machine learning, and natural language processing. This automation reduces the manual burden on human workers, ensuring that companies and organizations can stay compliant with current regulations.
  • Resource Optimization: By automating compliance processes, EnkrisiGPT helps free up valuable resources and time for drug sponsor organizations. This allows them to focus on other critical tasks and initiatives, increasing overall productivity and operational efficiency. With EnkrisiGPT, companies can optimize their workflows, maximize their resources, and achieve better outcomes.
  • EnkrisiGPT is experimental. Info quality may vary.
Discover the benefits of EnkrisiGPT for your business.

Thank you for your interest in the EnkrisiGPT Beta Version. We are excited to offer you the opportunity to explore the capabilities of this innovative tool. Before proceeding, we would like to outline some important points regarding this beta version:

  1. Beta Version Status: Please note that the EnkrisiGPT you will be accessing is a beta version. This means it is still in the testing phase and may not represent the final product.
  2. Confidentiality and Data Security: To ensure the utmost confidentiality and security of your data, we require a Confidentiality Disclosure Agreement (CDA) to be signed before you begin using Full Version EnkrisiGPT. This agreement will outline the terms of data usage, privacy, and non-disclosure of sensitive information.
  3. Provision of Key Source Information: For the EnkrisiGPT Full Version to function optimally and provide the most accurate and relevant responses, we would need specific key source information from your end. This information will help tailor the tool’s responses to your specific regulatory CMC needs.
  4. Feedback and Improvement: As this is a beta version, your feedback will be invaluable in helping us refine and enhance EnkrisiGPT. We encourage you to share your experiences, suggestions, and any issues you encounter.
  5. No Cost for Beta Access: Please be reminded that this beta version is being offered to you free of charge. Your participation and feedback are crucial in helping us develop a tool that truly meets the industry’s needs.

We are committed to supporting you throughout this beta phase and are eager to hear how Beta EnkrisiGPT assists in your regulatory CMC processes. Please let us know if you agree to these terms and are ready to proceed with the CDA and providing the necessary source information.

Thank you for being a part of this exciting journey with us.